Literature DB >> 23203767

Am80, a retinoic acid receptor agonist, ameliorates murine vasculitis through the suppression of neutrophil migration and activation.

Chie Miyabe1, Yoshishige Miyabe, Noriko N Miura, Kei Takahashi, Yuya Terashima, Etsuko Toda, Fumiko Honda, Tomohiro Morio, Naoko Yamagata, Naohito Ohno, Koichi Shudo, Jun-ichi Suzuki, Mitsuaki Isobe, Kouji Matsushima, Ryoji Tsuboi, Nobuyuki Miyasaka, Toshihiro Nanki.   

Abstract

OBJECTIVE: Vasculitis is characterized by leukocyte infiltration in the vessel walls, with destructive damage to mural structures. Retinoids are compounds that bind to retinoic acid receptors and exert biologic activities similar to those of vitamin A, including modulatory effects on cell proliferation and differentiation. This study was undertaken to examine the therapeutic effects of a synthetic retinoid, Am80, in a murine model of vasculitis induced by Candida albicans water-soluble fraction (CAWS).
METHODS: Vasculitis was induced in BALB/c mice by intraperitoneal injection of CAWS. Neutrophils were depleted by injection of antineutrophil antibody-positive serum. Am80 was administered orally once daily. Vasculitis was evaluated histologically. Migration of labeled adoptively transferred cells was quantified. Chemotaxis was assessed by cell mobility analysis. Production of reactive oxygen species (ROS) and phosphorylation of MAPKs were measured by flow cytometry. Concentrations of elastase were measured by enzyme-linked immunosorbent assay.
RESULTS: Administration of CAWS induced vasculitis in the coronary arteries and aortic root, with abundant neutrophil infiltration. Depletion of neutrophils reduced CAWS-induced vasculitis. Treatment with Am80 led to a significant attenuation of the vasculitis score and inhibition of the migration of transferred neutrophils into the site of vasculitis. In vitro, Am80 suppressed fMLP-induced chemotaxis of human peripheral blood neutrophils. ROS production and elastase release by stimulated neutrophils were reduced by AM80 treatment, and Am80 also inhibited phosphorylation of ERK-1/2 and p38 in neutrophils stimulated with fMLP plus lipopolysaccharide.
CONCLUSION: Am80 significantly suppressed CAWS-induced vasculitis. This effect was presumably exerted via inhibition of neutrophil migration and activation.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23203767     DOI: 10.1002/art.37784

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

Review 1.  Neutrophil migration: moving from zebrafish models to human autoimmunity.

Authors:  Miriam A Shelef; Sebastien Tauzin; Anna Huttenlocher
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

2.  Dectin-2-induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis.

Authors:  Chie Miyabe; Yoshishige Miyabe; Laura Bricio-Moreno; Jeffrey Lian; Rod A Rahimi; Noriko N Miura; Naohito Ohno; Yoichiro Iwakura; Tamihiro Kawakami; Andrew D Luster
Journal:  J Clin Invest       Date:  2019-06-06       Impact factor: 14.808

Review 3.  Could retinoids be a potential treatment for rheumatic diseases?

Authors:  Yoshishige Miyabe; Chie Miyabe; Toshihiro Nanki
Journal:  Rheumatol Int       Date:  2014-06-18       Impact factor: 2.631

4.  A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis.

Authors:  Chie Miyabe; Yoshishige Miyabe; Takaki Komiya; Hiroki Shioya; Noriko N Miura; Kei Takahashi; Naohito Ohno; Ryoji Tsuboi; Andrew D Luster; Shinichi Kawai; Nobuyuki Miyasaka; Toshihiro Nanki
Journal:  Inflamm Res       Date:  2016-12-10       Impact factor: 4.575

Review 5.  Chemokines in rheumatic diseases: pathogenic role and therapeutic implications.

Authors:  Yoshishige Miyabe; Jeffrey Lian; Chie Miyabe; Andrew D Luster
Journal:  Nat Rev Rheumatol       Date:  2019-11-08       Impact factor: 20.543

6.  Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis.

Authors:  Chie Miyabe; Yoshishige Miyabe; Jun Nagai; Noriko N Miura; Naohito Ohno; Jerold Chun; Ryoji Tsuboi; Hiroshi Ueda; Masayuki Miyasaka; Nobuyuki Miyasaka; Toshihiro Nanki
Journal:  Arthritis Res Ther       Date:  2019-08-20       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.